Bruker Corporation: Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics

Novel unbiased, in situ Spatial Single-Cell Metabolomics (SSCM) enables high-throughput metabolic tissue characterization with single-cell resolution New 5 µm microGRID technology for timsTOF

Related Keywords

Germany ,Heidelberg ,Baden Wüberg ,Denmark ,Copenhagen ,Køavn ,Petra Scheffer ,Theodore Alexandrov ,Molecular Medicine Partnership Unit ,Bioinnovation Institute ,International Conference Of The Metabolomics Society ,Bruker Daltonics Marketing Communications ,Biostudio Faculty Of The Bioinnovation Institute ,Bruker Corporation Nasdaq ,Investor Relations Corp Development ,Spatial Single Cell Metabolomics ,Predict Pro ,International Conference ,Metabolomics Society ,Bruker Corporation ,Metabolomics Core Facility ,Biostudio Faculty ,Daltonics Marketing Communications ,Director Investor Relations Corp Development ,Bruker ,Corporation ,Sushering ,1spatial ,Single ,Fell ,Metabolomics ,